HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Leonurine (SCM-198) attenuates myocardial fibrotic response via inhibition of NADPH oxidase 4.

Abstract
In our previous studies, we have reported that leonurine, a plant phenolic alkaloid in Herba leonuri, exerted cardioprotective properties in a number of preclinical experiments. Herein, we investigated the roles and the possible mechanisms of leonurine for reducing fibrotic responses in angiotensin II (Ang II)-stimulated primary neonatal rat cardiac fibroblasts and post-myocardial infarction (MI) rats. In in vitro experiments performed in neonatal rat cardiac fibroblasts, leonurine (10-20 μM) pretreatment attenuated Ang II-induced activation of extracellular signal-regulated kinase 1/2, production of intracellular reactive oxygen species (ROS), expression and activity of matrix metalloproteinase (MMP)-2/9, and expression of α-smooth muscle actin and types I and III collagen. A small interfering RNA-mediated knockdown strategy for NADPH oxidase 4 (Nox4) revealed that Nox4 was required for Ang II-induced activation of cardiac fibroblasts. In vivo studies using a post-MI model in rats indicated that administration of leonurine inhibited myocardial fibrosis while reducing cardiac Nox4 expression, ROS production, NF-κB activation, and plasma MMP-2 activity. In conclusion, our results provide the first evidence that leonurine could prevent cardiac fibrosis and the activation of cardiac fibroblasts partly through modulation of a Nox4-ROS pathway.
AuthorsXin-Hua Liu, Li-Long Pan, Hai-Yan Deng, Qing-Hui Xiong, Dan Wu, Guo-Ying Huang, Qi-Hai Gong, Yi-Zhun Zhu
JournalFree radical biology & medicine (Free Radic Biol Med) Vol. 54 Pg. 93-104 (Jan 2013) ISSN: 1873-4596 [Electronic] United States
PMID23127783 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2012 Elsevier Inc. All rights reserved.
Chemical References
  • NF-kappa B
  • RNA, Small Interfering
  • Reactive Oxygen Species
  • leonurine
  • Angiotensin II
  • Gallic Acid
  • NADPH Oxidase 4
  • NADPH Oxidases
  • Nox4 protein, rat
  • Extracellular Signal-Regulated MAP Kinases
  • Matrix Metalloproteinase 2
Topics
  • Angiotensin II (metabolism)
  • Animals
  • Cells, Cultured
  • Down-Regulation
  • Extracellular Signal-Regulated MAP Kinases (metabolism)
  • Fibroblasts (drug effects, metabolism, pathology)
  • Fibrosis
  • Gallic Acid (administration & dosage, adverse effects, analogs & derivatives)
  • Leonurus
  • Male
  • Matrix Metalloproteinase 2 (metabolism)
  • Myocardial Infarction (enzymology, pathology)
  • Myocardium (enzymology, pathology)
  • NADPH Oxidase 4
  • NADPH Oxidases (antagonists & inhibitors, genetics)
  • NF-kappa B (metabolism)
  • RNA, Small Interfering (genetics)
  • Rats
  • Rats, Sprague-Dawley
  • Reactive Oxygen Species (metabolism)
  • Signal Transduction (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: